• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • Instagram
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • What is ALS/MND
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights of People with ALS/MND and Caregivers
    • Research
      • Open Science
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
      • Open Label Extension
    • Advocacy
      • Advocacy Toolkit
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
    • Drugs in Development
      • AB Science – Masitinib
      • Amylyx – AMX0035
      • Biogen – Tofersen
      • BrainStorm Cell Therapeutics – NurOwn
      • Clene Nanomedicine – CNM-Au8
      • Collaborative Medicinal Development – CuATSM
      • Cytokinetics – Reldesemtiv
      • Kadimastem – AstroRx
      • Mitsubishi Tanabe Pharma America – Oral Edaravone
      • Orphazyme – Arimoclomol
      • T Regulatory Cell Therapies
    • Approved Drugs
      • Radicava/Edaravone
      • Neudexta
      • Riluzole/Tiglutik
  • Support for Health Professionals
    • How to Break the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Alliance Webinars
    • Alliance Meeting
    • Allied Professionals Forum
    • ALS/MND Connect
    • Global Day
    • March of Faces
    • International Symposium on ALS/MND
  • About
    • Who We Are
    • Board of Directors
    • Committees/Advisory Councils
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Innovation and Technology Council
      • Governance Committee
      • Budget and Finance Committee
    • Staff
    • History
    • Archives
      • Newsletters
      • Meetings
    • Awards
      • Student Award Nomination
      • Forbes Norris Award Nomination
      • Humanitarian Award Nomination
      • Allied Health Professional Award Nomination
  • Members
    • Member Registration
    • Forgot Password

Alliance Webinars

Upcoming Webinars

Please scroll down to watch our webinar recordings.

Genetic Counselling and Testing

March 29 @3:00 PM (EST)

Genetic Counselling

*English and Spanish captions available.

Familial or sporadic ALS/MND, the importance of genetic counselling and testing can´t be emphasized enough. Join us for this scenario-based discussion which will look at real situations ranging from an ALS/MND asymptomatic carrier to someone whose parent had ALS/MND, but has not done genetic testing.

Questions will be asked on family history, research, access, genetic discrimination and mental health.  

Panel:

  • Laynie Dratch – Genetic Counsellor
  • Ashley Crook – Genetic Counsellor
  • Jean Swidler – Confirmed C9orf72 mutation carrier
  • Jessica Mabe – Daughter of PALS, no genetic testing done to date

Moderator: Cathy Cummings – The International Alliance of ALS/MND Associations

Maintaining my independence

May 17 @7:00 AM (EST)

A panel with occupational therapists in ALS/MND providing recommendations for PALS at different stages of their journey. Tips, considerations, and what can be done at home

Scientific Advisory Council update & Q&A

June 21 @7:00 AM (EST)

A mid-year update from the Scientific Advisory Council.

Global Fundamental Rights Survey Results

September 7 @7:00 AM (EST)

The International Alliance of ALS/MND Associations surveyed the community about the Fundamental Rights of People living with ALS/MND and Caregivers. Learn more about the data, strengths and weaknesses at a global level, the questions raised and the topics that require further attention, and how these compared to our 2021 survey.

Mental Health Support for People Living with ALS/MND and Caregivers

September 27 @7:00 AM (EST)

We will discuss warning signs, how to safeguard, get help, and maintain mental health in people living with ALS/MND and caregivers.

Annual Global Clinical Trials Update

November 2 @7:00 AM (EST)

This webinar will provide information on ALS/MND treatments currently in Phase 3 Clinical Trials. We will hear directly about timelines, where the sites are, other programs offered, and who to contact if more information is needed.


Webinar Recordings

2023

Sharing Success: A Fireside Chat with the 2022 Award Winners

An informal conversation with the 2022 Award winners on their careers and their contributions to the field of ALS/MND. Panelists include Sally Light (Humanitarian Award recipient), Dr. Richard Bedlack (Forbes Norris Award recipient), and Richard Cave (Allied Health Professional Award recipient).

 

What Do I Need to Know About Clinical Trials?

Learn about the importance of clinical trials, how to find a suitable clinical trial, and what to consider if you want to take part and next steps. Moderated by Rachael Marsden. Panelists include Allison Bulat, Nadia Sethi & Paula Trefiak.

2022

FIRST ANNUAL GLOBAL CLINICAL TRIALS UPDATE This webinar provides information on ALS/MND treatments currently in Phase 3 Clinical Trials. We heard directly about timelines, where the sites are, other programs offered, and who to contact if more information is needed. Moderated by Gethin Thomas, Executive Director, Research – MND Australia, and Dr. Thanuja Dharmadasa, Senior Clinical Research Fellow at The Royal Melbourne Hospital and The Florey Institute of Neuroscience and Mental Health in Victoria, Australia. Enjoy presentations from AB Science, Amylyx, Biogen, Clene Nanomedicine, Cytokinetics, Ferrer, Ionis, and Mitsubishi Tanabe Pharma!

GENETIC COUNSELLING Join us in learning more about genetic counselling in ALS/MND. Genetic counsellor Ashley Crook will be providing us with an overview of genetic counselling, different types of genetic testing, and genetic counselling considerations before testing.

VOICE BANKING In this webinar we will learn more about the new assistive technology of voice banking.  . We will cover basic concepts, how it is done, timing, considerations and limitations. Moderator: Sara Feldman – ALS Hope Foundation. Panel: Alicia Gibb – MND New South Wales, Monique Signorelli – Motor Neurone Disease (MND) Clinic  – Communication and Assistive Technology (CAT) Clinic, Emily Kornman – Team Gleason, and Norman MacIsaac -PALS Perspective.

INNOVATION IN CLINICAL TRIAL DESIGN Clinical trial design is evolving in the ALS/MND community.  This webinar updates us on what the new models are, how they are changing the landscape and what are the practical implications for our community. Moderators: Gethin Thomas  – Executive Director, Research | Motor Neurone Disease Australia & Claire Magnussen, PhD – Program Manager | CAPTURE ALS, McGill University. Panel: Dr. Merit Cudkowicz  – HEALEY Trial, Dr. Ruben van Eijk – MAGNET Trial, Dr Suvankar Pal & Professor Siddharthan Chandran – SMART Trial.

APP DEMONSTRATION We demonstrate applications that can help people living with ALS/MND with their communication. Panel includes: Alper Kaya (Co-Chair of the Turkish ALS/MND Association & Person living with ALS/MND and Richard Cave (Speech and Language Therapist & Project Manager for MND Association).

SCIENTIFIC ADVISORY COUNCIL UPDATE & Q&A Mid-year update from the Alliance’s Scientific Advisory Council.

CARE PART 3: END OF LIFE This is not an easy topic, but one that is important to discuss. In this webinar we provided guidance on how PALS and CALS can address this stage of their journey, and what to look for in support and planning resources.

CARE PART 2: WHAT ARE MY ONGOING NEEDS WITH ALS/MND? This webinar addressed the questions: As ALS/MND progresses what are the ongoing needs of both people living with ALS/MND and their caregivers? And, how can those needs best be met? Moderated by Nick Goldup, Director of Care Improvement at MNDA UK.

CARE PART 1: WHAT DO I NEED TO KNOW AT DIAGNOSIS? In this webinar we explored the steps and actions people living with ALS/MND and their caregivers should consider at diagnosis to move forward in their ALS/MND journey.

GLOBAL SURVEY RESULTS The International Alliance of ALS/MND Associations surveyed the community about the Fundamental Rights of People living with ALS/MND and Caregivers. Learn more about the data, strengths and weaknesses at a global level, the questions raised and the topics that require further attention.

SHARING SUCCESS: A FIRESIDE CHAT WITH THE 2021 AWARD WINNERS An informal conversation with the 2021 Award winners on their careers, and their contributions to the field of ALS/MND.

2021

ETHICAL CONSIDERATIONS FOR GENETICS A discussion of the risks and benefits of genetic testing in individuals who are symptomatic or have a family history of ALS. Different contexts and potential considerations for individuals who are symptomatic for ALS, with and without a family history of ALS, or those who are asymptomatic for ALS but considering undergoing genetic testing will be discussed

GENETICS – COUNSELLING & TESTING This webinar touches on; what is genetic counselling and role of a genetic counsellor, what is involved in genetics counselling & testing, availability, awareness of ethical issues surrounding genetic testing, psychological effects of genetic testing and tackling difficult concepts in ALS/MND clinical genetics. Click here for information on our Moderators & Presenters.

INTRODUCTION TO ALS/MND GENETICS This webinar provides an overview of the current ALS/MND landscape and an understanding of genetics, so that people impacted by ALS/MND and their families have the basic tools to understand what this means and their options. Click here for information on our Moderators & Presenters.

OPTIMIZING CLINICAL TRIAL DESIGN From outcome measures to entry criteria, this webinar explores the lessons we have learned from the failed trials of the past, and how those have been integrated in to our optimization of clinical trials of the future.

YOUTH AND ALS/MND This webinar discusses the experience of a child whose parent has ALS/MND, and communication with a child to address their concerns and questions.

INNOVATION AND TECHNOLOGY IN ALS/MND This webinar explores several student projects that were part of the ‘Accessibility and Assistive Technologies’ module at University College London. Each project focused on the design of technologies for people living with ALS/MND that helps bridge the gap between the capabilities of the person and those required to conduct a task. “Until there is a cure, technology is the cure”.

BIOMARKERS IN ALS/MND This webinar provides an overview of biomarkers emerging as the front runners for the field, and how a combinatorial approach will likely be needed.

TELEMEDICINE BEST PRACTICES IN CARE & RESEARCH This webinar discusses best practices in telemedicine, for both care and research, for patients living with ALS/MND.

Q&A WITH THE ALLIANCE’S SCIENTIFIC ADVISORY COUNCIL A mid-year update of the Alliance’s Scientific Advisory Council in honour of Global ALS/MND Awareness Day.

Primary Sidebar

Events/Programs

  • Calendar of Events/Programs
  • Alliance Webinars
  • Alliance Meeting
  • Allied Professionals Forum
  • ALS/MND Connect
  • Global Day
  • March of Faces
  • International Symposium on ALS/MND

  • Francisco Perez Palop, Diagnosed 2013 - FUNDELA, Spain

    Francisco Perez Palop, Diagnosed 2013 – FUNDELA, Spain

  • Joy Blakeley, Diagnosed 2017 - MND Australia

    Joy Blakeley, Diagnosed 2017 – MND Australia

  • Chun Ju Xiao, China

    Chun Ju Xiao, China

  • Charlie “Hark” Dourney, Diagnosed 2007 - Hark ALS, USA

    Charlie “Hark” Dourney, Diagnosed 2007 – Hark ALS, USA

  • Monica Soriano, Diagnosed 2011 - Asociación ELA Argentina

    Monica Soriano, Diagnosed 2011 – Asociación ELA Argentina

  • Fabrice Kamp, Germany

    Fabrice Kamp, Germany

  • Phil Rossall, MND-Association, UK

    Phil Rossall, MND-Association, UK

  • Steven Gallagher, Canada

    Steven Gallagher, Canada

  • Mark Miller

    Mark Miller

  • Chris McCauley, Diagnosed 2015 - ALS Canada

    Chris McCauley, Diagnosed 2015 – ALS Canada

  • Osiel Mendoza, Diagnosed 2016 - ALS Therapy Development Institute, USA

    Osiel Mendoza, Diagnosed 2016 – ALS Therapy Development Institute, USA

  • Elisabeth Zahnd, Switzerland

    Elisabeth Zahnd, Switzerland

  • Alejandro Aquino, Diagnosed 2011 - Asociación ELA Argentina

    Alejandro Aquino, Diagnosed 2011 – Asociación ELA Argentina

  • Willi Klein

    Willi Klein

  • Irene McCaughey, Diagnosed 2011 - MND Australia

    Irene McCaughey, Diagnosed 2011 – MND Australia

  • Jeff Sutherland

    Jeff Sutherland
    jspic

  • Liong Ting Ngu, MND Malaysia, Diagnosed 2014, Malaysia

    Liong Ting Ngu, MND Malaysia, Diagnosed 2014, Malaysia

  • Philip Brindle, MND Association, Diagnosed 2015, England

    Philip Brindle, MND Association, Diagnosed 2015, England

  • Jon Newsome, Les Turner ALS Foundation, USA

    Jon Newsome, Les Turner ALS Foundation, USA

  • Eddy LeFrançois, Diagnosed 1992 - ALS Canada

    Eddy LeFrançois, Diagnosed 1992 – ALS Canada

  • Timothy Holman, Switzerland

    Timothy Holman, Switzerland

  • Steve Lufkin, USA

    Steve Lufkin, USA
    IMG_3993

  • Nicholas (Nic) Bowman, MND Association of South Africa, Diagnosed 2016, Australia

    Nicholas (Nic) Bowman, MND Association of South Africa, Diagnosed 2016, Australia

  • Erwin Coppejans, Diagnosed 2007 - ALS Liga België, Belgium

    Erwin Coppejans, Diagnosed 2007 – ALS Liga België, Belgium

  • Steven Spencer, Diagnosed 2014 - MND New Zealand

    Steven Spencer, Diagnosed 2014 – MND New Zealand

  • Jo Knowlton and her dog, Scotland

    Jo Knowlton and her dog, Scotland

  • Inta Grubb, Diagnosed 2014 - MND Australia

    Inta Grubb, Diagnosed 2014 – MND Australia

  • Roy

    Roy
    roy

  • Mike Rannie, ALS Canada, Diagnosed 2017, Canada

    Mike Rannie, ALS Canada, Diagnosed 2017, Canada

  • Wilfried Leusing, Diagnosed 2010 - DGM, Germany

    Wilfried Leusing, Diagnosed 2010 – DGM, Germany

  • John and Loretta Russo, USA

    John and Loretta Russo, USA
    final3878

  • Frank "Papa" Taylor

    Frank “Papa” Taylor

  • UK-Mahmood-Anwar

    UK-Mahmood-Anwar

  • Angie Bordaen, Diagnosed 2014 - ALS Liga België, Belgium

    Angie Bordaen, Diagnosed 2014 – ALS Liga België, Belgium

  • Zelina-Brito-Diagnosed-2018-Brazil

    Zelina-Brito-Diagnosed-2018-Brazil

  • Joanne Pratt, Diagnosed 2011 - MND Australia

    Joanne Pratt, Diagnosed 2011 – MND Australia

  • England-Lee-Millard, UK

    England-Lee-Millard, UK

  • Dorette Lüdi, Diagnosed 2014 - ALS Schweiz, Switzerland

    Dorette Lüdi, Diagnosed 2014 – ALS Schweiz, Switzerland

  • Marcel R. Wernard, Diagnosed 2016 - ALS Patients Connected, The Netherlands

    Marcel R. Wernard, Diagnosed 2016 – ALS Patients Connected, The Netherlands

  • Carlos Gomez Matallanas, Diagnosed 2014 - FUNDELA, Spain

    Carlos Gomez Matallanas, Diagnosed 2014 – FUNDELA, Spain

  • Valdomiro Xavier Honório, Brazil

    Valdomiro Xavier Honório, Brazil

  • Ali Var, Turkey

    Ali Var, Turkey

  • Brigitte Wernli, Association ALS Switzerland, Diagnosed 2014, Switzerland

    Brigitte Wernli, Association ALS Switzerland, Diagnosed 2014, Switzerland

  • Daniel Hare

    Daniel Hare

  • Kirsten Harley, Diagnosed 2013 - Australia

    Kirsten Harley, Diagnosed 2013 – Australia

  • David Watson, MND Scotland, Diagnosed 2018, Scotland

    David Watson, MND Scotland, Diagnosed 2018, Scotland

  • Guido De Mets, Belgium

    Guido De Mets, Belgium

  • Denis Blais, Diagnosed 2015 - ALS Canada

    Denis Blais, Diagnosed 2015 – ALS Canada

  • Len Johnrose, MND Association, Diagnosed 2017, England

    Len Johnrose, MND Association, Diagnosed 2017, England

  • Fernando Ocampo Cardona, Colombia

    Fernando Ocampo Cardona, Colombia

Learn more about the March of Faces

Latest Tweets

  • Just now

Subscribe to our Bi-Monthly Newsletter

Fill out the form below to subscribe to the Alliance’s bi-monthly newsletter, packed with updates from members associations from around the world!

Footer

Keep in touch

Sign up to receive updates and to hear what's going on in the International Alliance of ALS/MND Associations.

"*" indicates required fields

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • Instagram
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2023 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login